Compare Akamai Technologies, Inc. (AKAM) vs Morgan Stanley (MS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Akamai Technologies, Inc. vs Morgan Stanley — how do they compare? Akamai Technologies, Inc. trades at $117 (market cap $16.91B), while Morgan Stanley trades at $216.3 (market cap $338.50B). The key difference: Morgan Stanley is far larger — about 20× Akamai Technologies, Inc.'s market cap, and Morgan Stanley pays a 2.14% dividend while Akamai Technologies, Inc. pays none. Which is the better fit depends on your goals.
| AKAM | MS | |
|---|---|---|
Market Cap | $16.91B | $338.50B |
Sector | Technology | Financials |
52-Week High | $161.14 | $228.42 |
52-Week Low | $71.97 | $144.04 |
Enterprise Value | $22.89B | — |
Dividend Yield | — | 2.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Akamai Technologies (AKAM) trades at $110.54, down 6.76% over 24 hours, reflecting recent volatility despite strong Q2 2026 earnings beats. The stock shows bearish technical signals with support at $105 and resistance at $115, while fundamentals reveal revenue growth to $4.21 billion in 2025 but declining net margins to 9.51%. Analyst sentiment is mixed with a consensus price target of $152.60, and news highlights AI-driven cloud demand boosting performance.
Outlook remains cautious due to margin pressures from infrastructure investments, though AI and cybersecurity growth offer upside. Risks include competitive threats and execution challenges. Investors should weigh solid cash flow against high P/E of 40.05, with institutional hold ratings at 49.02% suggesting neutral near-term momentum.
Morgan Stanley (MS) trades at $215.1, down 0.54% on the day, with a neutral technical signal and key support at $214. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $3.46 surpassing expectations of $2.89. Revenue growth accelerated to $66.0B in 2025, and net income margin improved to 25.56%. Recent news highlights Morgan Stanley's role in leading Anthropic's IPO and expanding AI integration in wealth management.
The outlook remains positive with a consensus price target of $239.58, implying 11% upside. Strengths include robust profitability and strategic initiatives, but risks involve volatile cash flows from operations and high leverage. Analyst sentiment is bullish with 56% buy ratings, though investors should monitor debt levels and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Akamai Technologies, Inc.
Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,000 points of presence in more than 1,000 cities worldwide. Its customers generally include media companies, which stream video content or make video games available for download, and other enterprises that run interactive or high-traffic websites, such as e-commerce firms and financial institutions. Akamai also has a significant security business, which is integrated with its core web and media businesses to protect its customers from cyberthreats.
Read more on AKAM →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
